Kimia Therapeutics Stock Price Chart
Kimia Therapeutics specializes in unlocking deeper insights from empirical data to drive advancements in drug discovery. Their innovative approach combines precision chemistry with machine learning to accelerate the process of finding novel drugs. By merging active learning with automated synthesis and screening, their Atlas technology enables the identification of therapeutic targets and corresponding drug molecules, transforming the drug discovery landscape. Kimia's generative chemistry method leverages successive iterations of chemical design, high-throughput synthesis, chemical biology, and machine learning to create a map of the relationship between chemical structure and protein function, resulting in precise drug design. With Atlas precision chemistry, billions of target-directed compounds can be accessed, generating extensive chemical and biological data for analysis. Machine learning interprets this data to uncover valuable trends that inform future chemical design and lead optimization.
Legal Name
Kimia Therapeutics, Inc.
Kimia Therapeutics Stock Price History
Kimia Therapeutics stock is not currently traded in the private markets. We do not have enough data to print a price history for Kimia Therapeutics right now.
If you can share any Kimia Therapeutics stock trade data or funding round price per share, then we can start pricing coverage for Kimia Therapeutics.
Kimia Therapeutics Valuation
We are missing all Kimia Therapeutics funding round valuations. Sometimes these details are not shared in funding announcements or corporate filings.
If you can share valuations for any funding rounds that Kimia Therapeutics has done, then we can start valuation coverage for Kimia Therapeutics.
Kimia Therapeutics IPO
Kimia Therapeutics has not announced an official IPO date, IPO stock price, or filed a registration statement Form S-1 with the SEC. The Kimia Therapeutics IPO timeline is unknown.
An IPO for Kimia Therapeutics will likely need to clear the internal qualified public offering criteria in order receive shareholder approval.
When Kimia Therapeutics is ready to go public, they can IPO, SPAC or Direct List.
Does Kimia Therapeutics have stock?
Yes.
Investors usually get preferred stock and employees typically get common stock options or restricted stock units.
How to buy Kimia Therapeutics stock?
Kimia Therapeutics stock does not trade publicly on Nasdaq or NYSE because it is still a private company. Accredited investors are permitted to buy Kimia Therapeutics stock pre-IPO.
Private market transactions can be complex and often involve company approvals, legal purchase agreements and wires to third parties.
Trades can take 30 - 60 days to complete and that's why many investors hire experienced private market brokers to ensure things go smoothly. Notice members can message expert brokers for free to learn more about buying and selling private stocks.
What is the Kimia Therapeutics Stock Symbol?
Kimia Therapeutics does not have stock symbol nor does it trade in the public stock market because it is not a public company.
Kimia Therapeutics will choose a stock symbol or stock code prior to IPO.
Kimia Therapeutics will appear in the Notice stock ticker if it has recent private market activity.
Join Notice
We offer free access to the best private market intelligence available because we think everyone deserves to know the value of their private stock.
Create a free account